Zobrazeno 1 - 10
of 86
pro vyhledávání: '"OLA, THOMAS"'
Autor:
Ruth Link-Gelles, Daniel Westreich, Allison E. Aiello, Nong Shang, David J. Weber, Corinne Holtzman, Karen Scherzinger, Arthur Reingold, William Schaffner, Lee H. Harrison, Jennifer B. Rosen, Susan Petit, Monica Farley, Ann Thomas, Jeffrey Eason, Christine Wigen, Meghan Barnes, Ola Thomas, Shelley Zansky, Bernard Beall, Cynthia G. Whitney, Matthew R. Moore
Publikováno v:
SSM: Population Health, Vol 2, Iss , Pp 587-594 (2016)
In 2010, 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the US for prevention of invasive pneumococcal disease in children. Individual-level socioeconomic status (SES) is a potential confounder of the estimated effectiveness of PC
Externí odkaz:
https://doaj.org/article/12e51f0014bd4c77acdbc7c682510c2c
Autor:
Alper, Chester A., Husain, Zaheed, Larsen, Charles E., Dubey, Devendra P., Stein, Rosanne, Day, Caitlin, Baker, Alissa, Beyan, Huriya, Hawa, Mohammed, Ola, Thomas O., Leslie, R. David
Publikováno v:
In Journal of Autoimmunity 2006 27(2):89-95
Autor:
Ola, Thomas O., Biro, Paul A., Hawa, Mohammed I., Ludvigsson, Johnny, Locatelli, Mattia, Puglisi, Maria Ausiliatrice, Bottazzo, Gian Franco, Fierabracci, Alessandra
Publikováno v:
In Journal of Autoimmunity 2006 26(3):197-207
Autor:
Meghan Barnes, Bernard Beall, Ann Thomas, Arthur Reingold, Karen Scherzinger, Matthew R. Moore, Allison E. Aiello, Corinne Holtzman, Daniel Westreich, Jennifer B. Rosen, William Schaffner, Cynthia G. Whitney, Christine Wigen, Susan Petit, Jeffrey Eason, Ola Thomas, Ruth Link-Gelles, Monica M. Farley, Nong Shang, Shelley M. Zansky, Lee H. Harrison, David J. Weber
Publikováno v:
SSM-Population Health
SSM: Population Health, Vol 2, Iss, Pp 587-594 (2016)
SSM: Population Health, Vol 2, Iss, Pp 587-594 (2016)
In 2010, 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the US for prevention of invasive pneumococcal disease in children. Individual-level socioeconomic status (SES) is a potential confounder of the estimated effectiveness of PC
Publikováno v:
Annals of the New York Academy of Sciences. 2006, Vol. 1079 Issue 1, p81-89. 9p. 1 Chart.
Autor:
Ola, Thomas O.1 t.o.ola@qmul.ac.uk, Williams, Neil A.1 neil.a.williams@bristol.ac.uk
Publikováno v:
Immunology. Feb2006, Vol. 117 Issue 2, p262-270. 9p. 6 Graphs.
Autor:
Karla Wilson, Ola Thomas, F. Lennie Wong, J. C. K. Lee, Liton Francisco, Wendy Landier, Meghan Zomorodi, Claudia Herrera, Saro H. Armenian, Smita Bhatia, Clare Kasper
Publikováno v:
Journal of Clinical Oncology. 30:4401-4408
Purpose The Children's Oncology Group Long-Term Follow-Up (COG-LTFU) Guidelines use consensus-based recommendations for exposure-driven, risk-based screening for early detection of long-term complications in childhood cancer survivors. However, the y
Publikováno v:
Comparative Technology Transfer and Society. 7:115-145
Legislation concerning intellectual-property rights is changing, prompting universities around the world to focus more and more on the commercial potential of their research. One result is academic spin-offs. Our study compares academic spin-offs in
Autor:
Heeyoung Kim, Wendy Landier, Wendy B. London, Mary Lou Schmidt, Ola Thomas, F. Lennie Wong, Susan G. Kreissman, Lu Chen, J. C. K. Lee, Kristin Knight, Smita Bhatia, James G. Gurney
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(6)
Purpose Platinum-based therapy is the mainstay for management of high-risk neuroblastoma. Prevalence of platinum-related ototoxicity has ranged from 13% to 95% in previous reports; variability is attributable to small samples and disparate grading sc